Sepsis is a critical disease that is described by an uncontrolled immune response to an infection and is a primary cause of mortality. This irresistible immune response of a patient is also acknowledged as Systemic Inflammatory Response Syndrome (SIRS). In extreme cases of sepsis, the infection leads to a noteworthy drop in blood pressure called as septic shock. The septic shock will suddenly lead to failure of other organs of the body viz. lungs, liver and kidneys that may lead to death of patient. Healthcare compensations are improving significantly, which rises patients toward better treatment regimens. Rise in the number of products in the pipeline and upsurge in research & development expenditures are anticipated to be the leading factors which increases the growth of the sepsis therapeutics market.